BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cavazzana I, Andreoli L, Limper M, Franceschini F, Tincani A. Update on Antiphospholipid Syndrome: Ten Topics in 2017. Curr Rheumatol Rep 2018;20. [DOI: 10.1007/s11926-018-0718-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Gergianaki I, Bertsias G. Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. Front Med (Lausanne) 2018;5:161. [PMID: 29896474 DOI: 10.3389/fmed.2018.00161] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
2 Alijotas-reig J, Esteve-valverde E, Ferrer-oliveras R, Sáez-comet L, Lefkou E, Mekinian A, Belizna C, Ruffatti A, Tincani A, Marozio L, Espinosa G, Cervera R, Ríos-garcés R, De Carolis S, Latino O, Llurba E, Chighizola CB, Gerosa M, Pengo V, Lundelin K, Rovere-querini P, Canti V, Mayer-pickel K, Reshetnyak T, Hoxha A, Tabacco S, Stojanovich L, Gogou V, Varoudis A, Arnau A, Ruiz-hidalgo D, Trapé J, Sos L, Stoppani C, Martí-cañamares A, Farran-codina I. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. Autoimmunity Reviews 2019;18:406-14. [DOI: 10.1016/j.autrev.2018.12.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
3 Nahal SK, Selmi C, Gershwin ME. Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus. J Autoimmun 2018;93:16-23. [PMID: 30056945 DOI: 10.1016/j.jaut.2018.07.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
4 Szabó G, Antal-Szalmás P, Kerényi A, Pénzes K, Bécsi B, Kappelmayer J. Laboratory Approaches to Test the Function of Antiphospholipid Antibodies. Semin Thromb Hemost 2021. [PMID: 34261151 DOI: 10.1055/s-0041-1730357] [Reference Citation Analysis]
5 Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M. Management of antiphospholipid syndrome. Ann Rheum Dis 2019;78:155-61. [PMID: 30282668 DOI: 10.1136/annrheumdis-2018-213846] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
6 Egiziano G, Widdifield J, Rahman A, Vinet E, Moura CS, Curtis JR, Bernatsky S. Antiphospholipid Antibody Testing in a General Population Sample from the USA: An Administrative Database Study. Sci Rep 2020;10:3102. [PMID: 32080284 DOI: 10.1038/s41598-020-59990-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Pilania RK, Jindal AK, Guleria S, Gupta A, Ahluwalia J. Pseudovasculitic lesions in a boy with lupus. J Paediatr Child Health 2018;54:1275. [PMID: 30387246 DOI: 10.1111/jpc.2_14231] [Reference Citation Analysis]
8 Pericleous C, D'Souza A, McDonnell T, Ripoll VM, Leach O, Isenberg D, Giles I, Rahman A. Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events? Rheumatology (Oxford) 2020;59:146-52. [PMID: 31257438 DOI: 10.1093/rheumatology/kez239] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ferrer-Oliveras R, Mendoza M, Capote S, Pratcorona L, Esteve-Valverde E, Cabero-Roura L, Alijotas-Reig J. Immunological and physiopathological approach of COVID-19 in pregnancy. Arch Gynecol Obstet 2021;304:39-57. [PMID: 33945026 DOI: 10.1007/s00404-021-06061-3] [Reference Citation Analysis]
10 D'Ippolito S, Ticconi C, Tersigni C, Garofalo S, Martino C, Lanzone A, Scambia G, Di Simone N. The pathogenic role of autoantibodies in recurrent pregnancy loss. Am J Reprod Immunol 2020;83:e13200. [PMID: 31633847 DOI: 10.1111/aji.13200] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Gris JC, Mousty É, Bouvier S, Ripart S, Cochery-Nouvellon É, Fabbro-Peray P, Broner J, Letouzey V, Pérez-Martin A. Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the NOH-APS cohort. Haematologica 2020;105:490-7. [PMID: 31101755 DOI: 10.3324/haematol.2018.213991] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Polytarchou K, Varvarousis D, Manolis AS. Cardiovascular Disease in Antiphospholipid Syndrome. CVP 2020;18:538-48. [DOI: 10.2174/1570161117666190830101341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nascimento IS, Radin M, Gândara APR, Sciascia S, de Andrade DCO. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study. Lupus 2020;29:676-85. [DOI: 10.1177/0961203320916527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Leon-Martinez D, Mulla MJ, Han CS, Chamley LW, Abrahams VM. Modulation of trophoblast function by concurrent hyperglycemia and antiphospholipid antibodies is in part TLR4-dependent. Am J Reprod Immunol 2018;80:e13045. [PMID: 30194878 DOI: 10.1111/aji.13045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]